Non-Canonical Binding of a Small Molecule to Sortilin Alters Cellular Trafficking of ApoB and PCSK9 in Liver Derived Cells
R. P. Sparks, A. S. Arango, Z. L. Aboff, J. L. Jenkins, W. C. Guida, E. Tajkhorshid, C. E. Sparks, J. D. Sparks, R. A. Fratti
Abstract
Sortilin regulates hepatic exocytosis and endocytosis of ApoB containing lipoproteins (ApoB-Lp) and mediates the secretion of the subtilase PCSK9. To elucidate connections between these pathways, we previously identified a small molecule (cpd984) that binds to a non-canonical site on Sortilin. In hepatic cells cpd984 augments ApoB-Lp secretion, increases cellular PCSK9 levels, and reduces LDLR expression indicative of reduced secretion of PCSK9. We have shown that insulin-induced ApoB-Lp degradation occurs through Vps34-dependent autophagy. Here we show that the specific Vps34 inhibitor PIK-III enhances ApoB-100 secretion, reducing cellular levels of PCSK9 and Sortilin resulting in reduced LDLR expression, which implicates a role for autophagy in PCSK9 secretion. Results suggest that Sortilin is central to both PCSK9 and ApoB-100 secretion. Finally, we found that cpd984 in yeast blocks CPY secretion while increasing vacuolar homotypic fusion in a Vps10-dependent manner, indicating an evolutionarily conserved mechanism required for lysosomal protease trafficking.
02 /Specification & Classification
Click any tag to browse matching papersReproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Cell-associated, Heparin-like Molecules Modulate the Ability of LDL to Regulate PCSK9 Uptake
A. M. Galvan, J. S. Chorba·bioRxiv·May 23, 2018
- PCSK9 affects expression of key surface proteins in human pancreatic beta cells through intra- and extracellular regulatory circuits
K. Saitoski, M. Ryaboshapkina, … R. Scharfmann·bioRxiv·Sep 28, 2021
- ANGPTL3 binds to PCSK9 to coordinately regulate intracellular lipid homeostasis.
Simone Bini, Valeria Pecce, … Marcello Arca·bioRxiv·Jan 5, 2025
- Molecular interactions of PCSK9 with an inhibitory nanobody, CAP1 and HLA-C: functional regulation of LDLR levels
Carole Fruchart‐Gaillard, Ali Ben Djoudi Ouadda, … Nabil Georges Seidah·Molecular MetabolismPeer-reviewed·Dec 22, 2022
- Targeting Liver Epsins Ameliorates Dyslipidemia in Atherosclerosis through Inhibition of Proprotein Convertase Subtilisin/Kexin Type 9-Mediated Low-density Lipoprotein Receptor Degradation
Bo Zhu, Krishan Gupta, … Hong Chen·bioRxiv·Aug 26, 2024
- Hepatic inactivation of murine Surf4 results in marked reduction in plasma cholesterol
V. T. Tang, J. McCormick, … D. Ginsburg·bioRxiv·Aug 1, 2022